Funds played a key role in positioning LUMICKS for future success Amsterdam, the Netherlands — LUMICKS, a leading next generation life science tools company renowned for its innovative platforms for Dynamic Single-Molecule and Cell Avidity analysis, announces that it has made the decision to return the COVID-related relief funding it received in both the Netherlands […]
Michael Marks, Founding Partner for WRVI Capital, Joins the Atonarp Board and Former Berkeley Lights CFO Shaun Holt Joins as Atonarp’s Chief Operating Officer TOKYO — Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the healthcare, pharma, and semiconductor industries, today announced it has raised a $50 million Series D financing, led […]
Separation Will Create Focused, High-Growth Life Sciences and Automation Companies Tax-Efficient Separation Expected to be Completed by End of Calendar Year 2021 CHELMSFORD, Mass. — Brooks Automation, Inc. (“Brooks”) (Nasdaq: BRKS) today announced its intention to separate its business into two independent, and publicly-traded companies. The transaction is intended to be structured as a pro-rata distribution of […]
TwinStrand’s transformational improvements in DNA sequencing accuracy deliver 10,000x greater sensitivity, making it a crucial tool for genomic research and medicine Financing was led by Section 32 partner Michael Pellini, MD who has also joined the company’s Board of Directors TwinStrand Biosciences, the pioneer and developer of Duplex Sequencing, an ultra-high accuracy technology for revealing […]
M&G plc today announces that it has participated in a private transaction totalling £195 million, investing £35 million in Oxford Nanopore Technologies (Oxford Nanopore). The company was founded in 2005 as a spin-out from the University of Oxford. The investment has been made by M&G’s newly formed Catalyst team, who are investing up to £5 […]
Berlin: With the successful completion of a second closing, Labforward adds >€3m to the Series B from January, bringing the total funds raised to >€8.5m. The majority of the new investment comes from the Fielmann Family Office, majority owner of the leading German family business of the same name that serves its 27m customers across […]
Small Business Innovation Research Program Provides Seed Funding for R&D SAN DIEGO, CA, UNITED STATES — Allegro 3D, Inc. has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant for $997,692 to conduct research and development (R&D) work on a novel high-throughput biofabrication platform. This platform can create physiologically relevant in […]
BOSTON — Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced the close of the first $15 million of a planned $30 million Series C from a new life sciences investor. This investment will support the company in its mission to accelerate scientific discovery and speed the path from raw experimental data to new treatments and diagnostics. “Multi-omics tools are […]
Ultivue, a leader in advancing precision medicine solutions through a unique approach that combines multiplex biomarker analysis with same slide traditional H&E for tissue phenotyping, today announced the completion of a $50 million Series D round of financing. New investors include Ally Bridge Group, Pura Vida Investments and Tao Capital Partners. Previous venture investors in Ultivue […]
Company Plans Commercial Operations in 2021 MURRIETA, Calif. — Murrieta Genomics, the launch pad for genomic sequencing startups, has announced that simplSEQ, an incubator company, has completed its seed round funding, having received $2 million in total. Funds are to be used to validate the company’s novel sample preparation technology with external labs, further protect its patent-pending intellectual property and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
